Maine biologics regulations.

Who may administer PRP, exosomes and stem cells in Maine, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Maine?

In Maine, licensed medical practitioners such as physicians (MDs and DOs) and advanced practice providers under physician oversight are authorized to administer stem cell and other biologic treatments. Providers should be licensed through the Maine Board of Osteopathic Licensure or the Maine Board of Licensure in Medicine.

Official sources

Maine compliance guide.

FDA Compliance

Clinics offering biologics must comply with the FDA’s guidelines on human cells, tissues, and cellular and tissue-based products (HCT/P). These guidelines ensure that biologic therapies meet quality standards and are delivered safely to patients. Review the FDA’s Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) and Guidance Documents for more information.

State Regulations

Maine has specific guidelines governing the use and administration of biologics in clinical settings. These regulations are managed by the Maine Department of Health and Human Services (DHHS). Clinics should review and understand Maine’s regulatory framework to remain compliant with state laws. For more information, visit the Maine DHHS website.

Provider Qualifications

In Maine, licensed medical practitioners such as physicians (MDs and DOs) and advanced practice providers under physician oversight are authorized to administer stem cell and other biologic treatments. Providers should be licensed through the Maine Board of Osteopathic Licensure or the Maine Board of Licensure in Medicine. Providers must ensure they meet state licensing requirements and hold the necessary credentials.

Patient Informed Consent

Providers must obtain informed consent from patients before administering biologic therapies. Consent forms should outline potential risks, benefits, and the experimental nature of certain stem cell therapies. Consent documentation should clarify that some therapies are not yet fully validated by the FDA. This transparency helps protect both patients and providers.

Pre-Treatment and Post-Treatment Protocols

Establishing clear pre-treatment and post-treatment protocols can help ensure patient safety and streamline clinic operations. Pre-treatment protocols might include screening for contraindications, patient education, and baseline health assessments. Post-treatment follow-up is also essential for monitoring patient outcomes and addressing any adverse effects.

Standard Operating Procedures (SOPs)

Developing SOPs is crucial to maintain consistency and compliance across all biologic treatments offered. SOPs should cover key aspects of treatment protocols, patient communication, and documentation. This helps ensure all staff members follow the same processes.

Medical Liability Insurance

Providers should carry medical liability insurance specific to biologic treatments to protect their practice and patients. Insurance coverage should align with the services provided and any unique risks associated with biologics.

Marketing and Advertising Compliance

Marketing biologic therapies, especially experimental ones, requires compliance with state and federal advertising laws. Avoid making exaggerated or unproven claims about the benefits of stem cell therapies. All promotional materials should be factual, and any claims about effectiveness should be backed by reliable evidence to avoid legal repercussions.

This guide is a general summary to help clinics understand compliance requirements for biologics in Maine. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Maine: common questions.

Who can administer stem cells, PRP and exosomes in Maine?
In Maine, licensed medical practitioners such as physicians (MDs and DOs) and advanced practice providers under physician oversight are authorized to administer stem cell and other biologic treatments. Providers should be licensed through the Maine Board of Osteopathic Licensure or the Maine Board of Licensure in Medicine. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Maine?
FDA rules are federal, so they apply in Maine as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Maine?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Maine?
Start with the live webinar, then a discovery call and live training. After that we verify your Maine licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Maine? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.